For the latest COVID-19 (Coronavirus) information: CCTG public updates | CCTG member information

Group newsletter: CCTG Connection

Archived Bulletins

July 15, 2020

Published: July 15, 2020
Category: CCTG Bulletin

CCTG investigators are contributing to COVID-19 research by developing and leading innovative, cutting-edge clinical trials to support patients with cancer.

Read More

Published: July 15, 2020
Category: CCTG Bulletin

Congratulations to the 2019-2020 New Investigator Cancer Trials Practicum graduates!

Read More

Published: July 15, 2020
Category: CCTG Bulletin

The CCTG Trialblazers raised $7200 as part of the Canadian Cancer Society's Relay For Life "At Home" event. 

Read More

Published: July 15, 2020
Category: Trials

Trial-specific DSMC Summary Reports are now posted on trial websites. Single-study centres participating on these trials should download these reports and submit them to their Research Ethics Boards if required by local policy.

Read More

Published: July 15, 2020
Category: Publications

There were four recent publications, including the primary publication for CCTG CO.26: A Phase II Randomized Study of Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care Alone in Patients with Advanced Colorectal Adenocarcinoma Refractory to Standard Therapies.

Read More

Published: July 15, 2020
Category: Other

The CCTG Connection will be on hiatus until the Fall.

Read More

June 24, 2020

CCTG is very pleased to announce that Dr. Tim Whelan is the 2020 recipient of the CCTG Founder's Award - Dr. Joseph Pater Excellence in Clinical Trials Research. 

This award honours an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. This individual's research has provided techniques, information or concepts that will direct the future of the oncology research community and CCTG.

Read More

CCTG is very pleased to announce that Dr. Dan Renouf has been awarded the CCTG Dr. Ralph Meyer Phase III Program Young Investigator Award.

This award honours young investigators who have contributed significantly on CCTG phase III projects with CCTG Disease Site Committees, Endpoint Committees, or Working Groups.

“I’m very honored to both be nominated for and to receive this award. The mentorship provided to me by many members within CCTG is very much appreciated," says Dr. Renouf.

Read More